USPTO 2015–2025 USPTO PatentsView US Corporation

Avent, Inc.

USPTO PatentsView assignee record — 304 granted patents across 57 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

304
Total patents granted
57
CPC technology areas
13.3
Avg claims per patent
+16%
5-year filing velocity

Portfolio overview

Avent, Inc. has been granted 304 US utility patents between 2015 and 2025, placing Avent, Inc. at rank #1,379 across all assignees tracked by PlainPatent. This portfolio spans 57 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Avent, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 64.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 163 grants, compared with 141 in the 2015–2019 window — a +16% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Avent, Inc.'s 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 57 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Avent, Inc. against peers pursuing similar technology classes.

How does Avent compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Avent holds 304 patents — placing it at rank #1,379 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

1020304050 20152016201720182019202020212022202320242025 22
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Avent, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 32 10.5%
2016 32 10.5%
2017 26 8.6%
2018 29 9.5%
2019 22 7.2%
2020 24 7.9%
2021 13 4.3%
2022 40 13.2%
2023 34 11.2%
2024 30 9.9%
2025 22 7.2%

Which technologies does Avent, Inc. patent most?

Top 15 of 57 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#1,379

Across all tracked assignees

Innovation Score

64.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Avent, Inc. hold?
Avent, Inc. holds 304 US granted patents filed between 2015 and 2025, spanning 57 technology areas.
What is Avent, Inc.'s Innovation Score?
Avent, Inc. has an Innovation Score of 64.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Avent, Inc. focus on?
Avent, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 139 patents. The company has filed patents in 57 CPC subclasses total.
Is Avent, Inc.'s patent filing rate increasing or decreasing?
Avent, Inc.'s recent filing velocity is +16% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Avent, Inc.'s patents?
Avent, Inc.'s patents average 13.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Avent, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope